These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33598527)

  • 41. Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences.
    Lombardi G; Pupi A; Bessi V; Polito C; Padiglioni S; Ferrari C; Lucidi G; Berti V; De Cristofaro MT; Piaceri I; Bagnoli S; Nacmias B; Sorbi S
    J Alzheimers Dis; 2020; 77(1):203-217. PubMed ID: 32716357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline.
    Mielke MM; Aakre JA; Algeciras-Schimnich A; Proctor NK; Machulda MM; Eichenlaub U; Knopman DS; Vemuri P; Graff-Radford J; Jack CR; Petersen RC; Dage JL
    Alzheimers Dement; 2022 Apr; 18(4):602-611. PubMed ID: 34310832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
    Bellomo G; Cataldi S; Paciotti S; Paolini Paoletti F; Chiasserini D; Parnetti L
    Alzheimers Res Ther; 2020 Sep; 12(1):121. PubMed ID: 32993776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse.
    Alcolea D; Pegueroles J; Muñoz L; Camacho V; López-Mora D; Fernández-León A; Le Bastard N; Huyck E; Nadal A; Olmedo V; Sampedro F; Montal V; Vilaplana E; Clarimón J; Blesa R; Fortea J; Lleó A
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1815-1824. PubMed ID: 31464088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease.
    Meeker KL; Luckett PH; Barthélemy NR; Hobbs DA; Chen C; Bollinger J; Ovod V; Flores S; Keefe S; Henson RL; Herries EM; McDade E; Hassenstab JJ; Xiong C; Cruchaga C; Benzinger TLS; Holtzman DM; Schindler SE; Bateman RJ; Morris JC; Gordon BA; Ances BM
    Brain Commun; 2024; 6(2):fcae081. PubMed ID: 38505230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.
    Mielke MM; Frank RD; Dage JL; Jeromin A; Ashton NJ; Blennow K; Karikari TK; Vanmechelen E; Zetterberg H; Algeciras-Schimnich A; Knopman DS; Lowe V; Bu G; Vemuri P; Graff-Radford J; Jack CR; Petersen RC
    JAMA Neurol; 2021 Sep; 78(9):1108-1117. PubMed ID: 34309632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
    Janelidze S; Bali D; Ashton NJ; Barthélemy NR; Vanbrabant J; Stoops E; Vanmechelen E; He Y; Dolado AO; Triana-Baltzer G; Pontecorvo MJ; Zetterberg H; Kolb H; Vandijck M; Blennow K; Bateman RJ; Hansson O
    Brain; 2023 Apr; 146(4):1592-1601. PubMed ID: 36087307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light.
    Schindler SE; Karikari TK; Ashton NJ; Henson RL; Yarasheski KE; West T; Meyer MR; Kirmess KM; Li Y; Saef B; Moulder KL; Bradford D; Fagan AM; Gordon BA; Benzinger TLS; Balls-Berry J; Bateman RJ; Xiong C; Zetterberg H; Blennow K; Morris JC
    Neurology; 2022 Jul; 99(3):e245-e257. PubMed ID: 35450967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status.
    Bun S; Ito D; Tezuka T; Kubota M; Ueda R; Takahata K; Moriguchi S; Kurose S; Momota Y; Suzuki N; Morimoto A; Hoshino Y; Seki M; Mimura Y; Shikimoto R; Yamamoto Y; Hoshino T; Sato Y; Tabuchi H; Mimura M
    Alzheimers Res Ther; 2023 Sep; 15(1):149. PubMed ID: 37667408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrospinal Fluid Levels of β-Amyloid 40 and β-Amyloid 42 are Proportionately Decreased in Amyloid Positron-Emission Tomography Negative Idiopathic Normal-Pressure Hydrocephalus Patients.
    Kim HJ; Lim TS; Lee SM; Kim TS; Kim Y; An YS; Youn YC; Park SA; Chang J; Moon SY
    J Clin Neurol; 2019 Jul; 15(3):353-359. PubMed ID: 31286708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.
    Morenas-Rodríguez E; Li Y; Nuscher B; Franzmeier N; Xiong C; Suárez-Calvet M; Fagan AM; Schultz S; Gordon BA; Benzinger TLS; Hassenstab J; McDade E; Feederle R; Karch CM; Schlepckow K; Morris JC; Kleinberger G; Nellgard B; Vöglein J; Blennow K; Zetterberg H; Ewers M; Jucker M; Levin J; Bateman RJ; Haass C;
    Lancet Neurol; 2022 Apr; 21(4):329-341. PubMed ID: 35305339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity.
    Honig LS; Kang MS; Lee AJ; Reyes-Dumeyer D; Piriz A; Soriano B; Franco Y; Coronado ZD; Recio P; Mejía DR; Medrano M; Lantigua RA; Teich AF; Dage JL; Mayeux R
    JAMA Netw Open; 2023 Apr; 6(4):e238214. PubMed ID: 37079306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum.
    Lee J; Jang H; Kang SH; Kim J; Kim JS; Kim JP; Kim HJ; Seo SW; Na DL
    J Korean Med Sci; 2020 Nov; 35(44):e361. PubMed ID: 33200589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging.
    Schindler SE; Gray JD; Gordon BA; Xiong C; Batrla-Utermann R; Quan M; Wahl S; Benzinger TLS; Holtzman DM; Morris JC; Fagan AM
    Alzheimers Dement; 2018 Nov; 14(11):1460-1469. PubMed ID: 29501462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
    Hansson O; Seibyl J; Stomrud E; Zetterberg H; Trojanowski JQ; Bittner T; Lifke V; Corradini V; Eichenlaub U; Batrla R; Buck K; Zink K; Rabe C; Blennow K; Shaw LM; ;
    Alzheimers Dement; 2018 Nov; 14(11):1470-1481. PubMed ID: 29499171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Rodriguez JL; Snellman A; Suárez-Calvet M; Zetterberg H; Blennow K; Schöll M;
    Brain; 2021 Feb; 144(1):325-339. PubMed ID: 33257949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements.
    Nerattini M; Rubino F; Arnone A; Polito C; Mazzeo S; Lombardi G; Puccini G; Nacmias B; De Cristofaro MT; Sorbi S; Pupi A; Sciagrà R; Bessi V; Berti V
    Neurol Sci; 2022 Apr; 43(4):2469-2480. PubMed ID: 34739618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention.
    Udeh-Momoh C; Zheng B; Sandebring-Matton A; Novak G; Kivipelto M; Jönsson L; Middleton L
    J Prev Alzheimers Dis; 2022; 9(1):12-21. PubMed ID: 35098969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project.
    Willemse EAJ; van Maurik IS; Tijms BM; Bouwman FH; Franke A; Hubeek I; Boelaarts L; Claus JJ; Korf ESC; van Marum RJ; Roks G; Schoonenboom N; Verwey N; Zwan MD; Wahl S; van der Flier WM; Teunissen CE
    Alzheimers Dement (Amst); 2018; 10():563-572. PubMed ID: 30406175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.